Table: Hisamitsu - 6-MTH group results
Oct 10 (Reuters)-
Hisamitsu Pharmaceutical Co Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Aug 31, 2018 Aug 31, 2017 Feb 28, 2019
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 69.38 73.46 148.50
(-5.6 pct) (-1.3 pct) (+0.4 pct)
Operating 11.23 12.63 24.00
(-11.1 pct) (-1.9 pct) (-8.9 pct)
Recurring 12.01 12.87 26.30
(-6.7 pct) (+2.5 pct) (-6.9 pct)
Net 9.16 9.39 19.20
(-2.4 pct) (+1.1 pct) (+0.4 pct)
EPS 109.46 yen 112.19 yen 229.49 yen
EPS Diluted 109.36 yen 112.12 yen
Ann Div 82.00 yen 82.50 yen
-Q2 div 41.25 yen 41.00 yen
-Q4 div 41.00 yen 41.25 yen
NOTE - Hisamitsu Pharmaceutical Co Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T
Recent news on Hisamitsu Pharmaceutical Co
See all newsTable: Hisamitsu -2025/26 group results
Table: Hisamitsu -2025/26 parent results
Brief: Hisamitsu Pharmaceutical Co Inc - To Retire Treasury Shares Worth 6.34% Of Outstanding Stock On May 12
Brief: Hisamitsu Pharmaceutical Co Inc - Tender Offer Of Company By Taiyo Kosan Successfully Completed
Japan's Hisamitsu Pharmaceutical plans $2.55 billion MBO